Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 29, 2011 16:05 ET | Source: Stellar Biotechnologies, Inc.

Stellar Biotechnologies Awarded $498,560 Phase IIB National Science Foundation (NSF) Grant

PORT HUENEME, CA--(Marketwire - Aug 29, 2011) - Stellar Biotechnologies, Inc. "Stellar" (TSX-V: KLH) (PINKSHEETS: SBOTF) is pleased to announce that the National Science Foundation (NSF) has...
August 03, 2011 16:05 ET | Source: Stellar Biotechnologies, Inc.

Stellar Biotechnologies Announces a Strategic Agreement for Marketing and Sales With SAFC(R)

PORT HUENEME, CA--(Marketwire - Aug 3, 2011) - Stellar Biotechnologies, Inc. "Stellar" (TSX-V: KLH) (PINKSHEETS: SBOTF) is pleased to announce they have entered into an agreement for marketing and...
July 06, 2011 12:58 ET | Source: Stellar Biotechnologies, Inc.

Stellar Biotechnologies Presents Phase IIB Proposal to The U.S. National Science Foundation (NSF)

PORT HUENEME, CA--(Marketwire - Jul 6, 2011) - Stellar Biotechnologies, Inc. "Stellar" (TSX-V: KLH) (PINKSHEETS: SBOTF) is pleased to announce that its President, Frank Oakes and Executive VP,...
June 13, 2011 09:22 ET | Source: Stellar Biotechnologies, Inc.

Stellar Biotechnologies Releases Semi-Annual President's Letter to Shareholders

PORT HUENEME, CA--(Marketwire - Jun 13, 2011) - Stellar Biotechnologies, Inc. "Stellar" (TSX-V: KLH) (PINKSHEETS: SBOTF) is pleased to announce that its semi-annual CEO Letter to Shareholders has...
May 10, 2011 09:45 ET | Source: Stellar Biotechnologies, Inc.

Stellar Biotechnologies Announces Pre-IDE Meeting With FDA

PORT HUENEME, CA--(Marketwire - May 10, 2011) - Stellar Biotechnologies, Inc. (PINKSHEETS: SBOTF) (TSX-V: KLH) announces the completion of a pre-Investigational Device Exemption (pre-IDE) meeting...
March 08, 2011 08:55 ET | Source: Stellar Biotechnologies, Inc.

Stellar Biotechnologies Appoints Vice President, Business Development & Marketing

PORT HUENEME, CA--(Marketwire - March 8, 2011) - Stellar Biotechnologies, Inc. (PINKSHEETS: SBOTF) (TSX-V: KLH) has appointed Michael R. McClurg to VP, Business Development & Marketing. His...
January 25, 2011 08:55 ET | Source: Stellar Biotechnologies, Inc.

Stellar Biotechnologies Achieves Major Milestone

PORT HUENEME, CA--(Marketwire - January 25, 2011) - Stellar Biotechnologies, Inc. (TSX-V: KLH) (PINKSHEETS: SBOTF) is pleased to announce successful completion of preclinical toxicity and...
December 14, 2010 13:05 ET | Source: Stellar Biotechnologies, Inc.

Stellar Biotechnologies Receives Extension of NSF -- TECP Grant

PORT HUENEME, CA--(Marketwire - December 14, 2010) - Stellar Biotechnologies, Inc. (TSX-V: KLH) (PINKSHEETS: SBOTF) is pleased to announce that its U.S. subsidiary has been awarded a $99,000 grant...
December 07, 2010 08:50 ET | Source: Stellar Biotechnologies, Inc.

Stellar Biotechnologies' Exclusive License Agreement on Bayer Innovations/Stellar KLH Technology

PORT HUENEME, CA--(Marketwire - December 7, 2010) - Stellar Biotechnologies, Inc. (TSX-V: KLH) (PINKSHEETS: SBOTF) is pleased to announce that it has acquired an exclusive, irrevocable, worldwide,...
November 30, 2010 08:50 ET | Source: Stellar Biotechnologies, Inc.

Stellar Biotechnologies -- Independent KLH Toxicity & Immunogenicity Tests Complete

PORT HUENEME, CA--(Marketwire - November 30, 2010) - Stellar Biotechnologies, Inc. (TSX-V: KLH) (PINKSHEETS: SBOTF) www.StellarBiotechnologies.com announces completion of preclinical toxicity...